135 related articles for article (PubMed ID: 31315520)
1. The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia.
Cao LL; Liu H; Yue Z; Pei L; Wang H; Jia M
Hematology; 2019 Dec; 24(1):567-576. PubMed ID: 31315520
[No Abstract] [Full Text] [Related]
2. Maintenance DNA Methyltransferase Activity in the Presence of Oxidized Forms of 5-Methylcytosine: Structural Basis for Ten Eleven Translocation-Mediated DNA Demethylation.
Seiler CL; Fernandez J; Koerperich Z; Andersen MP; Kotandeniya D; Nguyen ME; Sham YY; Tretyakova NY
Biochemistry; 2018 Oct; 57(42):6061-6069. PubMed ID: 30230311
[TBL] [Abstract][Full Text] [Related]
3. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Matsuda I; Imai Y; Hirota S
J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
[TBL] [Abstract][Full Text] [Related]
4. Paternal aging and associated intraindividual alterations of global sperm 5-methylcytosine and 5-hydroxymethylcytosine levels.
Jenkins TG; Aston KI; Cairns BR; Carrell DT
Fertil Steril; 2013 Oct; 100(4):945-51. PubMed ID: 23809503
[TBL] [Abstract][Full Text] [Related]
5. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis.
Tang Y; Zheng SJ; Qi CB; Feng YQ; Yuan BF
Anal Chem; 2015 Mar; 87(6):3445-52. PubMed ID: 25675106
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic and cytotoxic properties of oxidation products of 5-methylcytosine revealed by next-generation sequencing.
Xing XW; Liu YL; Vargas M; Wang Y; Feng YQ; Zhou X; Yuan BF
PLoS One; 2013; 8(9):e72993. PubMed ID: 24066027
[TBL] [Abstract][Full Text] [Related]
7. Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
Chen Z; Shi X; Guo L; Li Y; Luo M; He J
Oncotarget; 2017 Jan; 8(1):1944-1952. PubMed ID: 27911867
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.
Globisch D; Münzel M; Müller M; Michalakis S; Wagner M; Koch S; Brückl T; Biel M; Carell T
PLoS One; 2010 Dec; 5(12):e15367. PubMed ID: 21203455
[TBL] [Abstract][Full Text] [Related]
9. Discrimination between 5-Hydroxymethylcytosine and 5-Methylcytosine in DNA via Selective Electrogenerated Chemiluminescence (ECL) Labeling.
Ma S; Sun H; Li Y; Qi H; Zheng J
Anal Chem; 2016 Oct; 88(20):9934-9940. PubMed ID: 27620533
[TBL] [Abstract][Full Text] [Related]
10. Preferential 5-Methylcytosine Oxidation in the Linker Region of Reconstituted Positioned Nucleosomes by Tet1 Protein.
Kizaki S; Zou T; Li Y; Han YW; Suzuki Y; Harada Y; Sugiyama H
Chemistry; 2016 Nov; 22(46):16598-16601. PubMed ID: 27689340
[TBL] [Abstract][Full Text] [Related]
11. Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.
Condliffe D; Wong A; Troakes C; Proitsi P; Patel Y; Chouliaras L; Fernandes C; Cooper J; Lovestone S; Schalkwyk L; Mill J; Lunnon K
Neurobiol Aging; 2014 Aug; 35(8):1850-4. PubMed ID: 24679604
[TBL] [Abstract][Full Text] [Related]
12. 5-methylcytosine and its derivatives.
Yuan BF
Adv Clin Chem; 2014; 67():151-87. PubMed ID: 25735861
[TBL] [Abstract][Full Text] [Related]
13. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
14. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
[TBL] [Abstract][Full Text] [Related]
15. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
Vasanthakumar A; Godley LA
Cancer Genet; 2015 May; 208(5):167-77. PubMed ID: 25892122
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine: the many faces of the sixth base of mammalian DNA.
Kriukienė E; Tomkuvienė M; Klimašauskas S
Chem Soc Rev; 2024 Mar; 53(5):2264-2283. PubMed ID: 38205583
[TBL] [Abstract][Full Text] [Related]
17. Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia.
Wernig-Zorc S; Yadav MP; Kopparapu PK; Bemark M; Kristjansdottir HL; Andersson PO; Kanduri C; Kanduri M
Epigenetics Chromatin; 2019 Jan; 12(1):4. PubMed ID: 30616658
[TBL] [Abstract][Full Text] [Related]
18. GADD45a physically and functionally interacts with TET1.
Kienhöfer S; Musheev MU; Stapf U; Helm M; Schomacher L; Niehrs C; Schäfer A
Differentiation; 2015; 90(1-3):59-68. PubMed ID: 26546041
[TBL] [Abstract][Full Text] [Related]
19. Functional impacts of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine at a single hemi-modified CpG dinucleotide in a gene promoter.
Kitsera N; Allgayer J; Parsa E; Geier N; Rossa M; Carell T; Khobta A
Nucleic Acids Res; 2017 Nov; 45(19):11033-11042. PubMed ID: 28977475
[TBL] [Abstract][Full Text] [Related]
20. The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies.
van den Hove DL; Chouliaras L; Rutten BP
Curr Alzheimer Res; 2012 Jun; 9(5):545-9. PubMed ID: 22272626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
